MDCX Institutional Ownership & Shareholders
MEDICUS PHARMA LTD (MDCX) is currently held by 21 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $473,385 based on the latest available SEC Form 13F filings for the quarter ended September 30, 2026.
Interchange Capital Partners, Llc is currently the largest disclosed institutional shareholder of MDCX tracked by InsiderSet, reporting ownership valued at approximately $342,879 in its September 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $4.14M, representing an estimated gain of +1108.47% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 97% of the total disclosed MDCX value among the investors covered in this analysis. Major shareholders include Interchange Capital Partners, Llc, Private Advisor Group, Llc, Corient Private Wealth Llc, and several other long-term asset managers with concentrated positions in MEDICUS PHARMA LTD (MDCX).
This page ranks the largest institutional MDCX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
21
Total Reported Value
$473,385
Largest Holder
Interchange Capital Partners, Llc
Largest Position
$342,879
Insider Transactions (90d)
0
Latest Filing Quarter
Q3 2026
New Institutional Positions
38
Funds Exiting Positions
1
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Interchange Capital Partners, Llc | 0.06% | 2,124,910 | $342,879 | $4,143,575 | +$3,800,696 | +1108.47% | |
| Private Advisor Group, Llc | 0.00% | 230,055 | $37,039 | $448,607 | +$411,568 | +1111.18% | |
| Corient Private Wealth Llc | 0.00% | 100,000 | $16,100 | $195,000 | +$178,900 | +1111.18% | |
| Sterling Investment Advisors, Ltd. | 0.00% | 100,000 | $16,100 | $195,000 | +$178,900 | +1111.18% | |
| Ubs Group Ag | 0.00% | 81,709 | $13,155 | $159,333 | +$146,178 | +1111.19% | |
| Commonwealth Equity Services, Llc | 0.00% | 73,863 | $11,890 | $144,033 | +$132,143 | +1111.38% | |
| May Hill Capital, Llc | 0.00% | 50,622 | $8,150 | $98,713 | +$90,563 | +1111.20% | |
| Stifel Financial Corp | 0.00% | 30,000 | $4,830 | $58,500 | +$53,670 | +1111.18% | |
| Susquehanna International Group, Llp | 0.00% | 28,904 | $4,654 | $56,363 | +$51,709 | +1111.06% | |
| Wilmington Savings Fund Society, Fsb | 0.00% | 25,622 | $4,125 | $49,963 | +$45,838 | +1111.22% | |
| Jpmorgan Chase & Co | 0.00% | 25,658 | $4,018 | $50,033 | +$46,015 | +1145.22% | |
| Sound View Wealth Advisors Group, Llc | 0.00% | 17,000 | $2,737 | $33,150 | +$30,413 | +1111.18% | |
| Lpl Financial Llc | 0.00% | 11,012 | $1,773 | $21,473 | +$19,700 | +1111.13% | |
| Foundations Investment Advisors, Llc | 0.00% | 11,000 | $1,771 | $21,450 | +$19,679 | +1111.18% | |
| Stonex Group Inc. | 0.00% | 10,965 | $1,765 | $21,382 | +$19,617 | +1111.43% | |
| Osaic Holdings, Inc. | 0.00% | 7,500 | $1,200 | $14,625 | +$13,425 | +1118.75% | |
| Royal Bank Of Canada | 0.00% | 4,625 | $1,000 | $9,019 | +$8,019 | +801.88% | |
| Morgan Stanley | 0.00% | 1,000 | $161 | $1,950 | +$1,789 | +1111.18% | |
| Wells Fargo & Company/Mn | 0.00% | 200 | $32 | $390 | +$358 | +1118.75% | |
| Smithfield Trust Co | 0.00% | 24,614 | $4 | $47,997 | +$47,993 | +1199832.50% | |
| Summit Global Investments | 0.00% | 15,000 | $2 | $29,250 | +$29,248 | +1462400.00% |
Frequently asked questions about MDCX
Who are the largest institutional holders of MDCX?
The largest institutional holders of MDCX reported in the latest SEC Form 13F filings include Interchange Capital Partners, Llc, Private Advisor Group, Llc, Corient Private Wealth Llc, Sterling Investment Advisors, Ltd., and Ubs Group Ag. InsiderSet ranks institutional holders by their latest reported MDCX position.
What is MDCX institutional ownership?
This page tracks MDCX positions reported by institutional investment managers through SEC Form 13F. MEDICUS PHARMA LTD (MDCX) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.
How many institutions own MDCX?
InsiderSet currently tracks 21 institutional managers reporting MDCX holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of MDCX shareholders.
How much MDCX stock do institutions own?
Institutional investment managers disclosed approximately $473,385 in MDCX holdings for Q3 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.
When was MDCX institutional ownership last updated?
The latest MDCX institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended September 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.
Are institutional MDCX holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its MDCX position after the reporting date.
Are institutions buying or selling MDCX?
Institutional buying and selling can be analyzed by comparing MDCX positions across consecutive 13F reporting periods. InsiderSet's MDCX Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View MDCX ownership changes.
How has MDCX institutional ownership changed over time?
InsiderSet tracks MDCX institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.